Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls
Figure 4
IFN-γ production in response to the positive control PHA (a) or a mix of ML1601c peptides no. 11 and no. 16 (b) measured after 24 h culture of undiluted whole blood derived from 34 Ethiopian healthy controls (ECs) derived from areas with low endemicity for leprosy () or from areas highly endemic for leprosy ().
